FDA — authorised 25 March 2011
- Application: BLA125377
- Marketing authorisation holder: BRISTOL MYERS SQUIBB
- Local brand name: YERVOY
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Yervoy on 25 March 2011
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 25 March 2011; FDA has authorised it.
BRISTOL MYERS SQUIBB holds the US marketing authorisation.